FDA approves Mylan's biosimilar of Roche's cancer drug Herceptin
(Reuters) - The U.S. Food and Drug Administration on Friday approved Mylan NV's biosimilar version of Roche's blockbuster breast cancer treatment Herceptin.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Health | Herceptin